EUVIMEDEUVIMED entdecken
Crossref

Anoectochilus roxburghii polysaccharide reduces D-GalN/LPS-induced acute liver injury by regulating the activation of multiple inflammasomes

Yulu Yan iD, Xiqi Ye, Chunqing Huang, Junjun Wu, Yunbiao Liu, Pingping Zheng, Congqi Shen, Zhaofang Bai iD, Shen Tingming

Journal of Pharmacy and Pharmacology · 01.09.2024 · 76 (9) · 1212-1224

DOI: 10.1093/jpp/rgae077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 01.09.2024. Verfasst von Yulu Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ningde Hospital of Traditional Chinese Medicine, Fujian University of Traditional Chinese Medicine, Fujian, 352100, China. Hauptthemen laut MEDLINE: Inflammasomes, Galactosamine, NLR Family, Pyrin Domain-Containing 3 Protein, Lipopolysaccharides. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute liver injury (ALI) is a serious syndrome with a high mortality rate due to viral infection, toxic exposure, and autoimmunity, and its severity can range from mildly elevated liver enzymes to severe liver failure. Activation of the nod-like receptor pyrin domain-containing 3 (NLRP3) inflammasome is closely associated with the development of ALI, and the search for an inhibitor targeting this pathway may be a novel therapeutic option. Anoectochilus roxburghii polysaccharide (ARP) is a biologically active ingredient extracted from Anoectochilus roxburghii with immunomodulatory, antioxidant, and anti-inflammatory bioactivities and pharmacological effects. In this study, we focused on D-galactosamine (D-GalN)/lipopolysaccharide (LPS)-induced acute liver injury by ARP through inhibition of NLRP3 inflammasome.

Methods

An inflammasome activation model was established in bone marrow-derived macrophages (BMDMs) to investigate the effects of ARP on caspase-1 cleavage, IL-1β secretion, and ASC oligomerization in inflammasomes under different agonists. We used the D-GalN/LPS-induced acute liver injury model in mice, intraperitoneally injected ARP or MCC950, and collected liver tissues, serum, and intraperitoneal lavage fluid for pathological and biochemical indexes.

Results

ARP effectively inhibited the activation of the NLRP3 inflammasome and had an inhibitory effect on non-classical NLRP3, AIM2, and NLRC4 inflammasomes. It also effectively inhibited the oligomerization of apoptosis-associated speck-like protein (ASC) from a variety of inflammatory vesicles. Meanwhile, ARP has good therapeutic effects on acute liver injury induced by D-GaIN/LPS.

Conclusion

The inhibitory effect of ARP on a wide range of inflammasomes, as well as its excellent protection against acute liver injury, suggests that ARP may be a candidate for acute liver injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammasomesGalactosamineNLR Family, Pyrin Domain-Containing 3 ProteinLipopolysaccharidesPolysaccharidesChemical and Drug Induced Liver InjuryMice, Inbred C57BLAnimalsMiceMaleOrchidaceaeMacrophagesDisease Models, AnimalInterleukin-1betaAnti-Inflammatory AgentsLiverCaspase 1

Stichwörter der Autor:innen

Anoectochilus roxburghii polysaccharideD-GaIN/LPSacute liver injuryinflammasomes

Substanzen

InflammasomesGalactosamineNLR Family, Pyrin Domain-Containing 3 ProteinLipopolysaccharidesPolysaccharidesNlrp3 protein, mouseInterleukin-1betaAnti-Inflammatory AgentsCaspase 1

Autor:innen und Institutionen

  • Ningde Hospital of Traditional Chinese Medicine, Fujian University of Traditional Chinese Medicine, Fujian, 352100, China.
  • Pingnan County Hospital of Traditional Chinese Medicine, Ningde City, Fujian Province, 352300, China.
  • Shouning County Hospital of Traditional Chinese Medicine, Ningde City, Fujian Province, 355500, China.
  • Shanxi University of Traditional Chinese Medicine, 030619,China.
  • China Military Institute of Chinese Materia, Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China.

ORCID-Profile: Yulu Yan, Zhaofang Bai

Zitieren

APA

Yan, Y., Ye, X., Huang, C., Wu, J., Liu, Y., Zheng, P., Shen, C., Bai, Z., & Tingming, S. (2024). Anoectochilus roxburghii polysaccharide reduces D-GalN/LPS-induced acute liver injury by regulating the activation of multiple inflammasomes. Journal of Pharmacy and Pharmacology, 76(9), 1212-1224. https://doi.org/10.1093/jpp/rgae077

Vancouver

Yan Y, Ye X, Huang C, Wu J, Liu Y, Zheng P, et al. Anoectochilus roxburghii polysaccharide reduces D-GalN/LPS-induced acute liver injury by regulating the activation of multiple inflammasomes. Journal of Pharmacy and Pharmacology. 2024;76(9):1212-1224. doi:10.1093/jpp/rgae077

BibTeX
@article{Yan2024,
  author = {Yan, Yulu and Ye, Xiqi and Huang, Chunqing and Wu, Junjun and Liu, Yunbiao and Zheng, Pingping and Shen, Congqi and Bai, Zhaofang and Tingming, Shen},
  title = {Anoectochilus roxburghii polysaccharide reduces D-GalN/LPS-induced acute liver injury by regulating the activation of multiple inflammasomes},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2024},
  volume = {76},
  number = {9},
  pages = {1212--1224},
  doi = {10.1093/jpp/rgae077}
}
Kostenlos starten →